Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,540 | 529 | 99.9% |
| Consulting Fee | $9.75 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,956 | 130 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $951.50 | 67 | $0 (2023) |
| Gilead Sciences, Inc. | $838.21 | 51 | $0 (2024) |
| PFIZER INC. | $457.60 | 24 | $0 (2024) |
| Janssen Biotech, Inc. | $441.95 | 31 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $330.39 | 22 | $0 (2024) |
| GENZYME CORPORATION | $329.01 | 14 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $313.96 | 19 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $296.86 | 20 | $0 (2024) |
| Celgene Corporation | $276.89 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,138 | 65 | ABBVIE INC. ($245.10) |
| 2023 | $1,240 | 71 | ABBVIE INC. ($270.20) |
| 2022 | $1,421 | 83 | ABBVIE INC. ($390.84) |
| 2021 | $1,173 | 73 | AbbVie Inc. ($331.96) |
| 2020 | $765.44 | 52 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($208.53) |
| 2019 | $1,021 | 69 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($212.54) |
| 2018 | $822.17 | 55 | AbbVie, Inc. ($163.81) |
| 2017 | $968.79 | 62 | AbbVie, Inc. ($172.49) |
All Payment Transactions
530 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.55 | General |
| 11/14/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/12/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $12.64 | General |
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Immunology | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: GI COLON PREP | ||||||
| 09/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Rare Disease | ||||||
| 09/05/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: GI | ||||||
| 08/27/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/23/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Biosimilars | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.94 | General |
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 687 | 709 | $489,345 | $77,884 |
| 2022 | 13 | 749 | 778 | $528,731 | $83,496 |
| 2021 | 13 | 943 | 985 | $478,595 | $83,926 |
| 2020 | 13 | 947 | 1,023 | $436,600 | $78,592 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 76 | $106,096 | $16,077 | 15.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 151 | 152 | $127,984 | $12,335 | 9.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 49 | 49 | $48,314 | $9,032 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 117 | $32,175 | $7,619 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $26,818 | $6,371 | 23.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $48,780 | $5,829 | 11.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $23,800 | $4,751 | 20.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 43 | $16,641 | $4,223 | 25.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $18,734 | $3,509 | 18.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 24 | $7,296 | $2,468 | 33.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $13,804 | $2,064 | 15.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 21 | $5,019 | $2,011 | 40.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $9,438 | $1,175 | 12.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 13 | 13 | $4,446 | $421.19 | 9.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 81 | 81 | $113,076 | $16,306 | 14.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 172 | 172 | $144,824 | $14,029 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $41,986 | $9,966 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 152 | $39,550 | $9,652 | 24.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 52 | 52 | $51,272 | $9,596 | 18.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 56 | 56 | $60,704 | $7,290 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 58 | $20,712 | $4,710 | 22.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $16,762 | $3,034 | 18.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $12,810 | $2,902 | 22.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $6,080 | $2,160 | 35.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $11,832 | $1,795 | 15.2% |
About Dr. Jae Nam, MD
Dr. Jae Nam, MD is a Gastroenterology healthcare provider based in Lawrenceville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477581999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jae Nam, MD has received a total of $8,550 in payments from pharmaceutical and medical device companies, with $1,138 received in 2024. These payments were reported across 530 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,540).
As a Medicare-enrolled provider, Nam has provided services to 3,326 Medicare beneficiaries, totaling 3,495 services with total Medicare billing of $323,897. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lawrenceville, GA
- Active Since 06/30/2006
- Last Updated 01/25/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1477581999
Products in Payments
- XIFAXAN (Drug) $602.77
- DUPIXENT (Biological) $521.58
- HUMIRA (Biological) $456.55
- STELARA (Biological) $424.63
- RINVOQ (Biological) $347.38
- XELJANZ (Drug) $345.63
- TRULANCE (Drug) $323.73
- OCALIVA (Drug) $313.96
- VIBERZI (Drug) $298.98
- Humira (Biological) $280.37
- ZEPOSIA (Drug) $255.64
- Linzess (Drug) $247.09
- SKYRIZI (Biological) $206.73
- LINZESS (Drug) $200.72
- ZENPEP (Drug) $157.78
- Creon (Drug) $134.74
- Entyvio (Biological) $122.02
- INJECTAFER (Drug) $118.76
- EUCRISA (Drug) $111.97
- ENTYVIO (Biological) $110.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lawrenceville
Long Nguyen, D.o, D.O
Gastroenterology — Payments: $112,688
Dr. Jyotsna Talapaneni, M.d.,, M.D.,
Gastroenterology — Payments: $11,742
Mark Kukler, D.o, D.O
Gastroenterology — Payments: $8,904
Scott Schorr, M.d, M.D
Gastroenterology — Payments: $8,790
Dr. William Tanner, M.d, M.D
Gastroenterology — Payments: $8,732
Dr. Srinivasa Ayinala, Md, MD
Gastroenterology — Payments: $8,149